Recall of 3i T3, Full Osseotite Tapered & Parallel Walled Dental Implants

According to Department of Health, Therapeutic Goods Administration, this recall involved a device in Australia that was produced by Biomet 3i Australia Pty Ltd.

What is this?

A correction or removal action taken by a manufacturer to address a problem with a medical device. Recalls occur when a medical device is defective, when it could be a risk to health, or when it is both defective and a risk to health.

Learn more about the data here
  • Type of Event
    Recall
  • Event ID
    RC-2014-RN-01222-1
  • Event Risk Class
    Class II
  • Event Initiated Date
    2014-12-02
  • Event Country
  • Event Source
    DHTGA
  • Event Source URL
  • Notes / Alerts
    Australian data is current through July 2018. All of the data comes from the Australian Therapeutic Goods Administration, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Australia.
  • Extra notes in the data
  • Reason
    Biomet 3i has identified a visually observable condition which may be present on a limited number of the identified implants. the condition is caused by the implant coming into contact with residual machining fluid which was not adequately degreased from a portion of 1 lot of packaging cylinders. the residual machining fluid causes the implants to be discoloured. biomet 3i has determined that there are no known health effects of the residue. this has been confirmed through cytotoxicity and endotoxicity tests, which have yielded negative results for toxins on residue-affected samples.
  • Action
    No affected units are known to have been implanted in Australia. Customers are advised to return affected products to BIOMET 3i Australia Pty Ltd for replacement with unaffected units. This action has been closed-out on 14/07/2016.

Device

  • Model / Serial
    3i T3, Full Osseotite Tapered & Parallel Walled Dental Implants3i T3 Non-Platform Switched Tapered Implant 3.25X8.5 -15.0mmCatalog Number BOST3211Lot Numbers: 2014051395 (Expiry: 12/11/2018), 2014051817 (Expiry: 12/09/2018)Full Osseotite Certain Implant 3.25X8.5 - 15.0mmCatalog Number XIFNT3211 Lot Number 2014051477 (Expiry: 12/06/2018)Parallel Walled Certain 2 Implant 3.25X8.5 - 18mmCatalog Number: XIFOSM311Lot Number: 2014051368 (Expiry: 12/03/2018)ARTG Number100482
  • Manufacturer

Manufacturer

  • Manufacturer Parent Company (2017)
  • Manufacturer comment
    “The safety of patients has always been, and continues to be, Zimmer Biomet’s top priority and it is our honor to be a leader in this industry for the past 90 years,” Zimmer Biomet told ICIJ in a statement. “We adhere to strict regulatory standards, and work closely with the FDA and all applicable regulatory agencies in each of our regions as part of our commitment to operating a first-rate quality management system across our global manufacturing network. The company added that it is focused on staying at the forefront of innovation and doing right by the millions of patients who rely on the company’s products.
  • Source
    DHTGA